The AACR and the FDA briefed patient advocates about cancer clinical trials during COVID-19 and the FDA’s recently issued COVID-19 Related Guidance Documents.
Cancer Survivor and Patient Advocacy Program
Building upon the AACR’s longstanding commitment to foster partnerships with cancer survivors and patient advocates—and to fulfill its goal of significantly expanding these relationships—the association established the Cancer Survivor and Patient Advocacy Program in 2004.
The AACR’s Cancer Survivor and Patient Advocacy Program is dedicated to fostering mutually beneficial and enduring partnerships among leaders of the cancer survivor, patient advocacy, and scientific communities.
By strengthening communications and developing collaborations among these key constituencies, the program enhances efforts to accelerate progress against cancer. To advance the prevention and cure of the disease, it is critical that advocates and scientists work together to increase funding for cancer research, further participation in clinical trials, improve clinical trial design, and facilitate access to cancer information for the general public. The Cancer Survivor and Patient Advocacy Program strengthens and supports these synergistic collaborations.
Opportunities for patient advocates
Cancer survivors and patient advocates provide valuable insight throughout the research continuum to inform scientific discovery, public policy, and clinical research. To encourage participation in research, AACR offers patient advocates and cancer survivors a number of resources, tools, and opportunities, such as:
- Scientist↔Survivor Program®
- Patient Advocate Affiliate Membership
- Patient Advocate Registration Rate at Scientific Conferences
- Patient Advocate Program at the AACR Annual Meeting
- Education and Inspiration for Patient Advocates
- Cancer Today, a magazine for patient advocates
Join our email list to get news and updates about AACR’s Patient Advocacy Programs.Sign up